Camlin Tierney

Related Links

Biography

Camlin Tierney, PhD, is a Senior Research Scientist in the Department of Biostatistics at the Harvard T.H. Chan School of Public Health, where she serves as a senior statistician at the Center for Biostatistics in AIDS Research (CBAR) and as Associate Director for the Statistical and Data Analysis Center (SDAC) for the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network. Her work includes overseeing as the lead statistician the study design, implementation, monitoring and analyses of small Phase I through to large multisite Phase III studies that evaluate interventions for HIV and HIV-associated complications and co-morbidities in infants, children, and adolescents, and during pregnancy and postpartum. She is co-author on lead medical and HIV journal publications cited in United States and World Health Organization (WHO) guidelines for the treatment of HIV and of hepatitis B. Her research includes HIV cure/remission in very early treated children, and pregnancy outcome definitions. She serves on data safety monitoring boards, and trains and mentors early career biostatisticians.

Education and Training

• Ph.D., Biostatistics
  University of Washington

Publications

• Effects of Combination Antiretroviral Therapy and Nutritional Rehabilitation on Growth in Children Aged 6-36 Months with Severe Acute Malnutrition in IMPAACT Protocol P1092.

  Mmbaga BT, Ngocho JS, Tierney C, Ziemba L, Reding C, Bone F, Bradford S, Costello D, Browning R, Moye J, Vhembo T, Mambiya S, Msowoya E, Owor M, Musoke P. J Pediatric Infect Dis Soc 2024 Aug 24

  PMID: 38808862

• Impact of Human Immunodeficiency Virus Drug Resistance Mutations Detected in Women Prior to Antiretroviral Therapy With Efavirenz + Tenofovir Disoproxil Fumarate + Lamivudine (or Emtricitabine).

  Boyce CL, Sils T, Milne RS, Wallner JJ, Hardy SR, Ko D, Wong-On-Wing A, Mackey M, Higa N, Beck IA, Styrchak SM, DeMarrais P, Tierney C, Fowler MG, Frenkel LM. Open Forum Infect Dis 2024

  PMID: 39050228

• Prevalence of detectable HIV-DNA and HIV-RNA in cerebrospinal fluid of youth with perinatal HIV and impaired cognition on antiretroviral therapy.

  Wagner TA, Tierney C, Huang S, Nichols S, Malee KM, Montañez NA, Coletti A, Spiegel HML, Krotje C, Bone F, Wilkins M, Abuogi L, Purswani M, Bearden A, Wiznia A, Agwu A, Chadwick EG, Richman D, Gandhi M, Mehta P, Macatangay B, Spector SA, Spudich S, Persaud D, Chahroudi A. AIDS 2024 Aug 01

  PMID: 38814693

• HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115): a phase 1/2 proof-of-concept study.

  Persaud D, Bryson Y, Nelson BS, Tierney C, Cotton MF, Coletti A, Jao J, Spector SA, Mirochnick M, Capparelli EV, Costello D, Szewczyk J, Nicodimus N, Stranix-Chibanda L, Kekitiinwa AR, Korutaro V, Reding C, Carrington MN, Majji S, Yin DE, Jean-Philippe P, Chadwick EG. Lancet HIV 2024 01

  PMID: 38061376

• Micronutrients and nutritional status among children living with HIV with and without severe acute malnutrition: IMPAACT P1092.

  Bwakura-Dangarembizi M, Ziemba L, Tierney C, Reding C, Bone F, Bradford S, Costello D, Browning R, Moye J, Vhembo T, Ngocho JS, Mallewa M, Chinula L, Musoke P, Owor M. BMC Nutr 2023 Nov 02

  PMID: 37919816